血液系统恶性肿瘤患者30年皮肤癌风险:荷兰全国人群研究
结果显示10年累积发病率分别为cSCC 2.6%、MM 0.5%、MCC 0.05%、BCC 4.8%,几乎所有亚组风险增加逾两倍,慢性淋巴细胞白血病患者风险最高。
要点
- 血液系统恶性肿瘤患者四种皮肤癌风险均显著升高,且持续超过30年。
- 慢性淋巴细胞白血病患者风险最高,SIR分别为cSCC 4.4、MM 2.7、MCC 9.3、BCC 2.6。
- 应加强患者防晒教育和定期皮肤自查,以早期发现皮肤癌。
核心结论
- 所有类型血液系统恶性肿瘤患者终生皮肤癌风险增加,尤以慢性淋巴细胞白血病为著。
主要发现
- 10年累积发病率:cSCC 2.6%、MM 0.5%、MCC 0.05%、BCC 4.8%。
- 几乎所有血液系统恶性肿瘤亚组四种皮肤癌风险均较一般人群增加逾两倍。
- 慢性淋巴细胞白血病患者SIR:cSCC 4.4、MM 2.7、MCC 9.3、BCC 2.6,风险持续超过30年。
临床怎么用
- 提高患者和医护人员对终生皮肤癌风险的认识。
- promote sun-protective measures and regular skin self-examinations in this high-risk population.
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with haematological malignancies are at increased risk of developing skin cancer and often experience worse skin cancer-related outcomes. However, there is a lack of nationwide, population-based data with long-term follow-up on the incidence and risks of different skin cancer types across all haematological malignancies. OBJECTIVES: To assess population-based risk estimates for cutaneous squamous cell carcinoma (cSCC), malignant melanoma (MM), Merkel cell carcinoma (MCC) and basal cell carcinoma (BCC) among patients with haematological malignancies, stratified by skin cancer type and haematological malignancy subgroup. These estimates can serve as a base for surveillance guidelines and patient education. METHODS: This nationwide population-based epidemiological cohort study used data from 210 794 patients diagnosed with a haematological malignancy between 1989 and 2020 from the Netherlands Cancer Registry (NCR). In addition, data on each type of histopathologically confirmed skin cancer per patient after haematological malignancy diagnosis were retrieved from the NCR. Patients with a history of skin cancer prior to their haematological malignancy were excluded. Cumulative incidences, standardized incidence ratios (SIRs) and absolute excess risks for each of the four skin cancers were calculated and stratified by haematological malignancy subgroup, age, sex, follow-up and primary treatment. RESULTS: The overall 10-year cumulative incidence of developing a first skin cancer was 2.6% for cSCC, 0.5% for MM, 0.05% for MCC and 4.8% for BCC. Compared with the general population, nearly all haematological malignancy subgroups showed more than a twofold increased risk of cSCC, MM, MCC and BCC. Patients with chronic lymphocytic leukaemia (CLL) showed the highest risks for each of the four skin cancers, with SIRs of 4.4 for cSCC, 2.7 for MM, 9.3 for MCC, and 2.6 for BCC. These elevated risks persisted for > 30 years after haematological malignancy diagnosis. CONCLUSIONS: Patients with all types of haematological malignancies, and especially those with CLL, have a lifetime increased risk of developing different types of skin cancer. These findings highlight the importance of creating awareness among patients and care providers about this increased risk and promoting sun-protective measures and regular skin self-examinations in this high-risk population. Due to advances in treatment, the life expectancy of people with blood cancers has improved. Therefore, it is important to understand the long-term health risks in these patients. This includes the risk of second cancers later in life. Skin cancer is the most common second cancer in patients with a blood cancer. A skin cancer called ‘basal cell carcinoma’ is the most common skin cancer diagnosis in the Netherlands. This is followed by another type called ‘cutaneous squamous cell carcinoma’. Melanoma is a less common type of skin cancer and Merkel cell carcinoma is even rarer. We looked at the risks of these four skin cancers in people after they were diagnosed with a blood cancer. Using data from the Netherlands Cancer Registry, we calculated the risks of skin cancers in patients with a blood cancer over 31 years (up to 2021). People with nearly all types of blood cancer had twice the risk of developing each of the four skin cancers than the general population. People with a type of blood cancer called ‘chronic lymphocytic leukaemia’ had the highest risk of developing a skin cancer. Our results show that patients and doctors need to know about the lifelong risk of skin cancer. As most skin cancers can be prevented, it is important for patients to protect their skin from the sun. They should also perform regular self-skin checks to detect cancers at an early stage.
引用
- Eggermont CJ, Hollatz A, Wakkee M, et al. Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands. Br J Dermatol. 2025. PMID: 39854282. doi:10.1093/bjd/ljaf027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。